German-French Diabetes Symposium
(Organized by: Ch. Boitard, E. Van Obberghen, H. Häring, M. Hrabé de Angelis)

  • Patrick Collombat, University of Nice Sophia Antipolis, France
    Induction of pancreatic beta-cell neogenesis
  • Agnès Lehuen, University of Paris V, France
    Mait cells at the crossroad of microbiota, inflammation and diabetes
  • Philippe Froguel, University of Lille, France and Imperial College, London, UK
    (Epi)genetics of Insulin Resistance

Translating Science to Clinics

  • Henning Beck-Nielsen, University of Copenhagen, Denmark
    Treatment of type 2 diabetes based on pathophysiology
  • Hans-Jürgen Wörle, Boehringer Ingelheim, Germany
    Empa Drug Development; past, present and future and its implications for future drug development

Future Concepts for Diabetes Therapy

  • Ron Kahn, Harvard Medical School, USA
    Impact of the Gut Microbiome on Insulin Receptor Signaling
  • Stephen O'Rahilly, University of Cambridge, UK
    Human metabolic disease, lessons from genetics

Special Lecture

  • Jeffrey Flier, Harvard Medical School, USA
    Irreproducibility of bioscience research: diagnosis, pathogenesis and therapy

The School will be chaired by members of the DZD executive board.

Source: NiceTourisme

Keep informed

 

@DiabResearch

Facts at a glance

Date:
April 19-22, 2017

DRS17: April 19, 2017
IR2017: April 20-22, 2017
Arrival of participants: April 18, 2017
Departure: April 23, 2017

Venue:
Centre Universitaire Méditerranéen, Nice

 

Participants:
PhD- and medical students as well as postdocs up to 35 years of age

Registration:
Registration includes free participation at DRS17 and IR2017 as well as free accommodation in double rooms (April 18-23).

APPLICATION closed

Notification of your acceptance:
January 17, 2017

Social program: 
tba

Contact:
Katrin Weber

phone: +49 89 3187 4718